How many drugs treat Menorrhagia?

Drug Landscape tracks 8 marketed treatments for Menorrhagia (deduplicated by molecule). 0 Phase 3 candidates and 0 Phase 2 candidates are in the pipeline.

How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/menorrhagia.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Menorrhagia — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Menorrhagia (disease) competitive landscape: 8 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

8 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Menorrhagia, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	First approval
Orgovyx	relugolix	MYOVANT SCIENCES	Gonadotropin Releasing Hormone Receptor Antagonist [EPC]	Gonadotropin-releasing hormone receptor	2020-01-01
Cyklokapron	TRANEXAMIC ACID	Exela Pharma	Antifibrinolytic Agent [EPC]	Plasminogen	1986-01-01
Jadelle	LEVONORGESTREL	Fdn Consumer	Progestin	Progesterone receptor	1968-01-01
Micronor	norethisterone	Johnson & Johnson	Progestin	GnRH receptors	1962-01-01
Noretynodrel	NORETHYNODREL	Pfizer	norethynodrel	Progesterone receptor	1961-01-01
Meclofenamate	Meclofenamate	Memorial Sloan Kettering Cancer Center		Aldo-keto reductase family 1 member C1, Aldo-keto reductase family 1 member C2, Aldo-keto reductase family 1 member C3
Amchafibrin	Amchafibrin	Fundación Pública Andaluza Progreso y Salud		Plasminogen
transamin	transamin	Erzincan Military Hospital		Plasminogen

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

· 3 drugs in Menorrhagia
Erzincan Military Hospital · 1 drug in Menorrhagia
Exela Pharma · 1 drug in Menorrhagia
Fdn Consumer · 1 drug in Menorrhagia
Fundación Pública Andaluza Progreso y Salud · 1 drug in Menorrhagia
Johnson & Johnson · 1 drug in Menorrhagia
MYOVANT SCIENCES · 1 drug in Menorrhagia
Memorial Sloan Kettering Cancer Center · 1 drug in Menorrhagia
Pfizer · 1 drug in Menorrhagia

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Menorrhagia:

Cite this brief

Drug Landscape (2026). Menorrhagia — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/menorrhagia. Accessed 2026-06-10.

Menorrhagia full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing